2010, Number 3
<< Back Next >>
Med Int Mex 2010; 26 (3)
Pancreatitis probably induced by tigecycline: a report of a case
Suárez OR, Espinoza LD, Ponce PA, Carrillo PC
Language: Spanish
References: 8
Page: 273-275
PDF size: 169.63 Kb.
ABSTRACT
Tigecycline is a novel glicylcicline, its structure is related with tetracyclines, tetracycline induced pancreatitis is a well known adverse reaction, the increase in the use of tigecycline has heightened the need for monitoring for adverse reactions. For tigecycline, we only found two cases reported on literature, here we present a case with suspected tigecycline-induced pancreatitis. Psysichian should be aware of this reaction.
REFERENCES
Rubinstein E, Vaughan D. Tigecycline: A novel glycylcycline. Drugs 2005;65(10):1317-1336.
MacGowan AP. Tigecycline pharmacokinetic/pharmacodynamic update. J Antimicrob Chemother 2008;62(Suppl.):11-16.
McKeage K, Keating GM. Tigecycline in community-acquired pneumonia. Drugs 2008;68(18):2633-2644.
Lipshitz J, Kruh J, Cheung P, et al. Tigecycline-induced pancreatitis. J Clin Gastroenterol 2009;43:93.
Marshall SR. Tigecycline-induced pancreatitis. Hosp Pharm 2009;44:239-241.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-245.
Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis. J Clin Gastroenterol 2005;39:709-716.
Mofidi R, Patil V, Suttie S, et al. Risk assessment in acute pancreatitis. BJSurg 2009;96:137-150.
Full text